欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1986/001
药品名称Lecigon
活性成分
    • Carbidopa monohydrate 5.0 mg/ml
    • Entacapone 20.0 mg/ml
    • Levodopa 20.0 mg/ml
剂型Intestinal gel
上市许可持有人LobSor Pharmaceuticals AB, Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Norway (NO)
    • Finland (FI)
    • Slovakia (SK)
    • Bulgaria (BG)
    • Spain (ES)
    • Croatia (HR)
    • Czechia (CZ)
      Lecigon
    • France (FR)
    • Hungary (HU)
      Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml intesztinális gél
    • Italy (IT)
    • Ireland (IE)
    • Belgium (BE)
      Lecigimon 20 mg/ml + 5 mg/ml + 20 mg/ml gel voor intestinaal gebruik
    • Austria (AT)
    • Germany (DE)
      Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml Gel zur intestinalen Anwendung
    • Netherlands (NL)
      Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml gel voor intestinaal gebruik
    • Romania (RO)
      Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml intestinal gel
    • Slovenia (SI)
    • Luxembourg (LU)
    • Poland (PL)
      Lecigon
    • Portugal (PT)
许可日期2019/09/24
最近更新日期2025/01/08
药物ATC编码
    • N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Repeat Use
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase